8-K: Current report filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report: February 24, 2006
_____________________________

VISUALANT, INCORPORATED
________________________________
(formerly Starberrys Corporation)
(Exact name of Registrant as specified in its charter)

Nevada 0-25541 91-1948357
________________________________________________________________________________
(State or jurisdiction of (Commission File No.) (IRS Employer
incorporation) Identification No.)

500 Union Street, Suite 406
Seattle, Washington 98101
(206) 903-1351
(Address of Registrant's principal executive office
and telephone number)
__________________________________________

Section 1 - Registrant's Business and Operations

Item 1.01 Entry into a Material Definitive Agreement.

On February 22, 2006, the Company terminated its research and development
contract with E-VISION TECHNOLOGIES INC. The Company intends to concentrate its
resources towards its primary research and development relationship with RatLab
LLC.

RatLab LLC is a research laboratory formed primarily by Dr. Thomas Furness,
founder and former director of the Human Interface Technology Lab (HitLab) at
the University of Washington, and one of the leading researchers in the world in
the area of human interface technology. Dr. Furness also is the founder of the
Virtual World Consortium, an organization of more than fifty leading technology
companies and enterprises dedicated to sharing and advancing research in many
scientific research areas important to the Company. The Company has been a
member of the Virtual World Consortium since July 2005. RatLab LLC also employs
other leading scientists and research associates in the areas of computer
science, imaging technology, and light sensing technology, who will be part of
the team conducting research on behalf of the Company.

Section 5 - Corporate Governance and Management

Item 5.02 Departure of Directors or Principal Officers; Election of
Directors; Appointment of Principal Officers.

On November 11, 2005, the Company also announced the termination of Ken Turpin
as the Chief Science Officer of the Company.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Registrant: VISUALANT, INCORPORATED


By: /s/ Jerry D. Goldberg
____________________________________________
Jerry D. Goldberg
Title: Chief Financial Officer and Secretary

Dated: February 24, 2006.